The Canadian Stroke Congress welcomes the submission of late-breaking scientific abstracts or on-going clinical trials starting June 10, 2015 through to July 15, 2015. Late-breaking scientific abstracts and ongoing clinical trials may be submitted using the on-line abstract submission site. Please follow the “Abstract Submission Guidelines” below.
Who May Submit?
Late-Breaking Scientific Abstracts
Late-breaking scientific abstracts should feature recent high-impact scientific discoveries. The Canadian Stroke Congress will not accept late-breaking scientific abstracts that have been accepted for an international meeting, and that will be published (print or online) and/or presented prior to October 1, 2015.
Late-breaking scientific abstracts will be peer reviewed but will not be published. Highly ranked late-breaking abstracts may be featured either as oral or traditional paper display posters.
Abstract Submission Guidelines
- Abstracts are welcome from national and international applicants from all disciplines. Authors may submit multiple abstracts.
- Abstracts may be submitted in English or French and presentations at the Congress may be given in either language.
- Presenters must register for the Congress and will be required to pay the appropriate registration fee.
- Applicants should categorize their abstract based on one of the six subject area categories provided in the abstract submission system.
- Applicants should indicate the format they would prefer to present their abstracts:
- Oral: A 10-minute oral presentation in a plenary or breakout session. Spaces are limited. Those who are not successful in securing an oral presentation slot will be offered to present their abstract via a mini-platform or display poster format.
- Display Poster: A traditional paper (non-digital) poster. Presenters will be asked to be available to answer questions during set times during the Congress. Display posters will be available for viewing to all Congress delegates throughout the Congress.
- All abstracts will be peer-reviewed.
- Each abstract should be a maximum of 300 words (excluding title and authors) and should consist of four separate paragraphs:
- Background: briefly describing the problem or issue being addressed
- Methods: describing how the study was performed
- Results: describing the salient results or findings
- Conclusions: describing what the authors conclude from these results.
- Research presented in abstracts must conform to CIHR guidelines for experimental procedures. All investigations involving humans and animals must have been conducted in conformity with these principles.
- Authors must declare any financial interest in a company (or its competitors) that makes a product discussed in the abstract.